01 9Cyramza
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,033
2019 Revenue in Millions : 925
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 1,033
2020 Revenue in Millions : 1,033
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 971
2021 Revenue in Millions : 1,033
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 975
2022 Revenue in Millions : 971
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 76
2014 Revenue in Millions : 384
Growth (%) : 405%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 614
2015 Revenue in Millions : 384
Growth (%) : 60
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 758
2016 Revenue in Millions : 614
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 821
2017 Revenue in Millions : 758
Growth (%) : 8%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 925
2018 Revenue in Millions : 821
Growth (%) : 13
LOOKING FOR A SUPPLIER?
